Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials - PubMed
7 hours ago
- #Meta-analysis
- #IgA nephropathy
- #Sibeprenlimab
- Sibeprenlimab shows efficacy and safety in treating IgA nephropathy based on systematic review and meta-analysis of randomized controlled trials.
- The study focuses on APril (A proliferation-inducing ligand) related mechanisms in IgA nephropathy.
- No competing interests declared among authors, with ethical approval and consent details noted as not applicable.
- References include key literature on IgA nephropathy pathogenesis, natural history, and long-term outcomes.